P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: P3 Health Partners (PIII) Q3 2026 MANAGEMENT VIEW * CEO, President & Director Aric Coffman said Q3 “reflect that work with $21 million of adjusted EBITDA, bringing our year-to-date adjusted EBITDA to $101 million,” and added, “we are raising the low end…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe higher EBITDA guidance can support the shares of this small healthcare company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01CEO Aric Coffman reports 21 million dollars of adjusted EBITDA in the third quarter.
- 02Year-to-date adjusted EBITDA reaches 101 million dollars.
- 03The low end of full-year guidance rises to 90 million and the midpoint to 100 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets